Actipulse Neuroscience Analysis
What is Actipulse Neuroscience?
Actipulse Neuroscience develops non-invasive brain stimulation technologies aimed at treating psychiatric and neurological disorders through transcranial neuromodulation devices.
Employees
38
Founded
2017
Revenue
$174K-$2.9M
Business Model
Revenue from hospital devices and shared-revenue model for recurring income.
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
- Non-Invasive Brain Stimulation technologies, transcranial neuromodulation devices, treatment for Major Depressive Disorder, oncology applications.
Pricing
- Treatment with Actipulse Home is anticipated to cost between $1,200 and $1,600 for a duration of approximately 3 months.
Who are the founders of Actipulse Neuroscience
AC
Adrien Châtillon
Founder
GV
Gabriel Villafuerte
Founder
Market Focus
Actipulse Neuroscience primarily focuses on the healthcare industry, specifically in the field of psychiatric and neurological disorders through the development of Non-Invasive Brain Stimulation technologies.
Competitors Overview
Actipulse Neuroscience operates in the Non-Invasive Brain Stimulation market, focusing on transcranial neuromodulation devices for psychiatric and neurological disorders. Its main competitors include:
- Emotra: Specializes in emotional assessment and treatment technologies, focusing on depress
Investors
- Y Combinator
- MassChallenge
- FoundersX Ventures
- Trav Walkowski
- Empire Group International
Company Pricing
- Treatment with Actipulse Home is anticipated to cost between $1,200 and $1,600 for a duration of approximately 3 months.
See something that needs updating? Suggest edits to this profile.